{"id":"W2522335594","doi":"10.1182/blood.v118.21.2701.2701","title":"First Evidence for High Incidence of Complete and Sustained Molecular Remissions and Maintenance of Immune Responses in Patients Receiving Consolidation with Y90 Ibritumomab Tiuxetan (90Y-RIT) Post R-CHOP for Newly Diagnosed Advanced Stage High and Intermediate Risk Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Ibritumomab tiuxetan; Internal medicine; Follicular lymphoma; Maintenance therapy; Regimen; Chemotherapy regimen; Gastroenterology; Clinical endpoint; Oncology; Chemotherapy; Lymphoma; Surgery; Radioimmunotherapy; Immunology; Clinical trial; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001555012,0.0002114398,0.0006397155,0.0001727744,0.0001666553,0.0004808779,0.0002946721,0.0006623561,0.003408641],"category_scores_gemma":[0.003275848,0.0002069666,0.0003745476,0.0001797949,0.0003713254,0.0003210421,0.0002122706,0.001046006,0.0004011394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002376117,"about_ca_system_score_gemma":0.0002593466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001347478,"about_ca_topic_score_gemma":0.0002241557,"domain_scores_codex":[0.9993419,0.0003179486,0.00004956365,0.00008797076,0.0001215373,0.00008113193],"domain_scores_gemma":[0.9947,0.002444508,0.001432402,0.000548051,0.0002345303,0.0006405202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1237926,0.002436803,0.7101867,0.000493302,0.001477932,0.00144626,0.0003093279,0.0004611316,0.02780647,0.0001852997,0.002509048,0.1288951],"study_design_scores_gemma":[0.004710301,0.04001299,0.9448632,0.00002474885,0.0006226131,0.003569115,0.00005483132,0.0007575788,0.002750739,0.000112935,0.002503379,0.00001748434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996668,0.001772839,0.0002111361,0.0001808014,0.00001704787,0.00004419541,0.00009215684,0.00001843877,0.000995358],"genre_scores_gemma":[0.9993001,0.0001411695,0.00008466385,0.000115268,0.00004616728,0.000009993757,0.0001134223,0.000003724819,0.0001854074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003408641,"threshold_uncertainty_score":0.01140302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01389354637163541,"score_gpt":0.2463578421288642,"score_spread":0.2324642957572289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}